BLEPHARITIS

Clinical trials for BLEPHARITIS explained in plain language.

Never miss a new study

Get alerted when new BLEPHARITIS trials appear

Sign up with your email to follow new studies for BLEPHARITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1 Completed 2 Terminated 1

New eye drop targets Mite-Related eyelid inflammation in phase 2 trial

Disease control Ongoing

This study tests a new eye drop (APT-001, containing spinosad 1.8%) for blepharitis, a condition causing red, irritated eyelids often linked to tiny mites. About 100 people with symptoms will receive either the active drop or a placebo. The goal is to see if the treatment clears …

Matched conditions: BLEPHARITIS

Phase: PHASE2 • Sponsor: Aperta Biosciences, LLC • Aim: Disease control

Last updated Jun 27, 2026 12:35 UTC

BLEPHARITIS

Get alerted when new BLEPHARITIS trials appear

New eye drop targets Mite-Related eyelid inflammation in phase 2 trial